title: Subcutaneous human hepatitis B immunoglobulin: scant assessment after liver transplantation for hepatitis B.
abstract: The only (non-comparative) trial of subcutaneous treatment, following intravenous administration, is insufficient to determine the impact on survival, re-infection, or the risk of potentially severe hypersensitivity reactions.
mesh_terms: D004342:Drug Hypersensitivity / Q000209:etiology; D006509:Hepatitis B / Q000628:therapy*; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000009:adverse effects; D007279:Injections, Subcutaneous; D016031:Liver Transplantation
chemical_list: D007136:Immunoglobulins; C045213:hepatitis B hyperimmune globulin